Oscar Health, Inc. $OSCR Stock Acquired by Genesee Capital Advisors LLC

Genesee Capital Advisors LLC lifted its position in Oscar Health, Inc. (NYSE:OSCR) by 227.8% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 44,338 shares of the company’s stock after buying an additional 30,814 shares during the period. Genesee Capital Advisors LLC’s holdings in Oscar Health were worth $1,367,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in the business. CoreCap Advisors LLC boosted its stake in Oscar Health by 526.3% during the 2nd quarter. CoreCap Advisors LLC now owns 1,190 shares of the company’s stock valued at $34,000 after purchasing an additional 1,000 shares during the last quarter. GAMMA Investing LLC raised its position in Oscar Health by 32.9% in the 2nd quarter. GAMMA Investing LLC now owns 1,441 shares of the company’s stock worth $41,000 after buying an additional 357 shares during the last quarter. Harel Insurance Investments & Financial Services Ltd. purchased a new position in Oscar Health in the 1st quarter worth about $49,000. FNY Investment Advisers LLC purchased a new position in Oscar Health in the 2nd quarter worth about $57,000. Finally, Allworth Financial LP lifted its stake in Oscar Health by 124.9% during the 2nd quarter. Allworth Financial LP now owns 2,031 shares of the company’s stock valued at $58,000 after acquiring an additional 1,128 shares during the period. 75.70% of the stock is owned by institutional investors.

Insider Buying and Selling

In other Oscar Health news, Director Mario Schlosser sold 600,000 shares of the business’s stock in a transaction that occurred on Thursday, August 27th. The stock was sold at an average price of $30.34, for a total transaction of $18,204,000.00. Following the sale, the director directly owned 480,866 shares of the company’s stock, valued at $14,589,474.44. The trade was a 55.51% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, insider Janet Liang sold 10,360 shares of the business’s stock in a transaction that occurred on Thursday, September 3rd. The shares were sold at an average price of $31.45, for a total value of $325,822.00. Following the transaction, the insider directly owned 248,697 shares in the company, valued at approximately $7,821,520.65. This represents a 4.00% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold a total of 874,451 shares of company stock valued at $26,761,671 in the last quarter. 22.64% of the stock is currently owned by insiders.

Oscar Health Price Performance

OSCR traded up $1.31 during trading hours on Tuesday, hitting $33.85. The company’s stock had a trading volume of 1,639,564 shares, compared to its average volume of 6,794,465. The business’s 50-day moving average price is $31.57 and its 200-day moving average price is $26.86. Oscar Health, Inc. has a 12 month low of $10.69 and a 12 month high of $35.01. The stock has a market cap of $10.45 billion, a price-to-earnings ratio of 24.15, a P/E/G ratio of 0.35 and a beta of 2.47. The company has a current ratio of 1.09, a quick ratio of 1.09 and a debt-to-equity ratio of 0.21.

Oscar Health (NYSE:OSCR) last released its quarterly earnings results on Thursday, August 6th. The company reported $1.10 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.40 by $0.70. Oscar Health had a net margin of 3.60% and a return on equity of 38.45%. The company had revenue of $4.88 billion for the quarter, compared to the consensus estimate of $4.73 billion. During the same quarter in the prior year, the firm earned ($0.89) earnings per share. Oscar Health’s revenue was up 70.4% on a year-over-year basis. Sell-side analysts expect that Oscar Health, Inc. will post 1.83 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several research analysts have weighed in on the company. Stephens restated an “equal weight” rating and issued a $34.00 price target on shares of Oscar Health in a research note on Thursday, September 17th. Wells Fargo & Company lifted their price objective on shares of Oscar Health from $20.00 to $27.00 and gave the company an “equal weight” rating in a research report on Thursday, August 13th. The Goldman Sachs Group reissued a “neutral” rating and issued a $34.00 target price on shares of Oscar Health in a report on Thursday, September 17th. Bank of America upped their target price on shares of Oscar Health from $28.00 to $30.00 and gave the stock an “underperform” rating in a research report on Thursday, September 17th. Finally, UBS Group raised their target price on shares of Oscar Health from $26.00 to $36.00 and gave the company a “neutral” rating in a research note on Monday, October 12th. One equities research analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $34.90.

About Oscar Health

Oscar Health, Inc is a technology-focused health insurance company that provides health plans and related services in the United States. The company primarily serves individuals and families purchasing coverage through the Affordable Care Act’s health insurance marketplace, as well as small businesses and their employees.

Oscar combines health insurance products with digital tools designed to help members manage their care. Its services include online enrollment, virtual care, provider search and appointment support, care navigation, claims and benefits information, and member engagement through web and mobile applications.